Two-tiered SARS-CoV-2 seroconversion screening in the Netherlands and stability of nucleocapsid, spike protein domain 1 and neutralizing antibodies ...
Serological testing in the COVID-19 pandemic is mainly implemented to gain sero-epidemiological data, but can also retrospectively inform about suspected SARS-CoV-2 infection. We verified and applied a two-tiered testing strategy combining a SARS-CoV-2 receptor-binding domain (RBD)-specific lateral flow assay (LFA) with a nucleocapsid protein (NCP) IgG ELISA to assess seroconversion in n = 7241 individuals. The majority had experienced symptoms consistent with COVID-19, but had no access to RT-PCR testing. Longitudinal follow-up in n = 97 LFA + individuals was performed up to 20 weeks after in... Mehr ...
Verfasser: | |
---|---|
Dokumenttyp: | dataset |
Erscheinungsdatum: | 2021 |
Verlag/Hrsg.: |
Taylor & Francis
|
Schlagwörter: | Medicine / Neuroscience / Biotechnology / Immunology / FOS: Clinical medicine / 80699 Information Systems not elsewhere classified / FOS: Computer and information sciences / 19999 Mathematical Sciences not elsewhere classified / FOS: Mathematics / Cancer / 110309 Infectious Diseases / FOS: Health sciences / 60506 Virology / FOS: Biological sciences / Computational Biology |
Sprache: | unknown |
Permalink: | https://search.fid-benelux.de/Record/base-29165756 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | https://dx.doi.org/10.6084/m9.figshare.14179954.v1 |